Expression of multiple growth factors in a human lung cancer cell line
Christer Betsholtz(Uppsala University), Bengt Westermark(Science for Life Laboratory), Rolf Ohlsson(Uppsala University), Jonas Bergh(Karolinska Institutet), James Scott(MRC Clinical Trials Unit at UCL), Ann Johnsson(Uppsala University), Graeme I. Bell(University of Chicago), Carl‐Henrik Heldin(Ludwig Cancer Research), Margaret Bywater(Uppsala University Hospital), Timothy J. Knott(MRC Clinical Trials Unit at UCL), M Pettersson
Cited by 64
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
|Physiological Reviews|1999|2.5k
Role of platelet-derived growth factors in physiology and medicine
|Genes & Development|2008|2.4k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k